British Patient Capital
Overview
British Patient Capital is the UK's largest domestic investor in venture and venture growth opportunities . With more than £3bn of assets under management, its mission is to enable long-term investment in innovative UK companies led by ambitious entrepreneurs who want to build successful, world-class businesses . By focusing on the late-stage funding gap, it helps ensure high-growth UK companies have access to the right type of funding at the right time in their life-cycle, supporting them as they expand, create jobs, develop products and enter new markets .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lendable | Mar 2022 | Growth Equity | - |
| Thought Machine | May 2022 | Series D | Co-investor |
| Quantexa | Mar 2025 | Series F | - |
| Zego | Mar 2021 | Series C | - |
| Pragmatic Semiconductor | Dec 2023 | Series D | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is British Patient Capital based?
British Patient Capital is headquartered in United Kingdom.
When was British Patient Capital founded?
British Patient Capital was founded in 2018.
How many portfolio companies does British Patient Capital have?
British Patient Capital has 32 portfolio companies in Caplight's dataset.
What are some companies in British Patient Capital's portfolio?
Portfolio companies visible on Caplight include Lendable, Thought Machine, Quantexa, Zego, Pragmatic Semiconductor.
What was British Patient Capital's most recent investment shown here?
British Patient Capital's most recent investment in this portfolio sample was in Quantexa in 2025.
What sectors does British Patient Capital focus on?
British Patient Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, FinTech, FinTech, FinTech, Frontier & Industrial Tech, Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Energy & Sustainability, AI, Data & Cloud Infrastructure, FinTech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Energy & Sustainability, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Mobility, Transportation & Logistics, Enterprise Software, Consumer & Commerce, Enterprise Software.
What company stages does British Patient Capital focus on?
British Patient Capital typically invests at the Mid stage.
What is British Patient Capital's AUM?
British Patient Capital's assets under management are estimated between $1.0B and $10.0B.